CStone Pharmaceuticals (“CStone”, HKEX: 2616) today announces the dosing of the first patient in China for the Phase I registrational study of BLU-667, which was discovered by the company’s partner Blueprint Medicines. This clinical trial is a part...
A preclinical trial of a tenofovir disoproxil fumarate (TDF) intravaginal ring for HIV pre-exposure prophylaxis ended early after 8 of 12 women unexpectedly developed vaginal ulcers. The National Institutes of Health-funded study, published in The Lancet, included 17...
I Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing potentially best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced enrollment of the first patient in an...
Saul Priceman, Ph.D., City of Hope assistant professor in the Department of Hematology & Hematopoietic Cell Transplantation, and his research team have received a $9.28 million award from the California Institute for Regenerative Medicine (CIRM) to support a...
TEL AVIV, Israel, Aug. 12, 2019 /PRNewswire/ — Following the one month data of the 9th patient, the Data and Safety Monitoring Board (DSMB) reviewed the safety data from Cellect Biotechnology Ltd.’s (Nasdaq: APOP) ongoing Phase 1/2 clinical study...
Mark Terry for Biospace writes: Last week was a particularly busy week for biopharma companies to release information about ongoing clinical trials. Here’s a look. Pfizer announced that its Phase III RESET clinical trial evaluating rivipansel in sickle cell disease...
Email
Text